Trial Profile
Impact of Intravenous Exenatide Versus Insulin on Quality of Life in Cardiac Surgery Patients: an Ancillary Study of the ExSTRESS Phase II/III Clinical Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Hyperglycaemia; Postoperative complications
- Focus Therapeutic Use
- Acronyms ExeQOL
- 05 Mar 2021 Status changed from recruiting to completed.
- 08 May 2015 New trial record
- 07 May 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.